Hematopoietic Stem Cell TransplantationPeripheral Blood Stem Cell TransplantationTransplantation, AutologousTransplantation, HomologousBone Marrow TransplantationStem CellsGraft vs Host DiseaseTransplantation ConditioningStem Cell TransplantationHematopoietic Stem CellsHematopoietic Stem Cell MobilizationImmunosuppressive AgentsBone MarrowTreatment OutcomeHematologic NeoplasmsBone Marrow CellsGranulocyte Colony-Stimulating FactorCord Blood Stem Cell TransplantationAntigens, CD34LeukapheresisGraft SurvivalTissue DonorsAdult Stem CellsTransplantationBlood Component RemovalCytomegalovirus InfectionsCombined Modality TherapyMelphalanMultiple MyelomaEmbryonic Stem CellsBusulfanPluripotent Stem CellsHistocompatibility TestingHistocompatibilityImmunocompromised HostCyclophosphamideWhole-Body IrradiationRecurrenceStem Cell NicheOpportunistic InfectionsCell DifferentiationHematopoiesisRetrospective StudiesAntineoplastic Combined Chemotherapy ProtocolsTransplantation ChimeraLeukemiaTime FactorsNeural Stem CellsMesenchymal Stem Cell TransplantationInduced Pluripotent Stem CellsStem Cell FactorFetal BloodBone Marrow PurgingMultipotent Stem CellsHematologic DiseasesLymphoma, Non-HodgkinAnemia, AplasticRemission InductionMyeloablative AgonistsBlood CellsPlant StemsMycosesKidney TransplantationCell LineageSurvival RateSalvage TherapyCells, CulturedCytomegalovirusBone Marrow DiseasesAspergillosisColony-Forming Units AssaySurvival AnalysisFlow CytometryBlood Cell CountLeukemia, Myeloid, AcuteMesenchymal Stromal CellsRoseolovirus InfectionsFatal OutcomeInfectionLeukemia, Myelogenous, Chronic, BCR-ABL PositiveCell SeparationTransplantsNeoplastic Stem CellsDisease-Free SurvivalHepatic Veno-Occlusive DiseaseVidarabineHodgkin DiseaseNeoplasmsPrecursor Cell Lymphoblastic Leukemia-LymphomaCyclosporineAcute DiseaseEtoposideFollow-Up StudiesBlood DonorsLymphocyte DepletionAntineoplastic Agents, AlkylatingMyelodysplastic SyndromesLeukocyte TransfusionImmunosuppressionGanciclovir